Immatics (IMTX) Non-Current Deferred Tax Liability (2022 - 2025)
Immatics (IMTX) reported Non-Current Deferred Tax Liability of $4.4 million for Q4 2025, down 28.55% on a YoY basis from $6.2 million in Q4 2024, and up 3.06% sequentially from $4.3 million in Q3 2025.
Immatics (IMTX) Non-Current Deferred Tax Liability (2022 - 2025) Analysis & Trends
Immatics (IMTX) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $4.4 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Deferred Tax Liability fell 28.55% year-over-year to $4.4 million; the trailing twelve-month figure through Dec 2025 stood at $4.4 million (down 28.55% YoY), and the FY2025 full-year result was $4.3 million, down 31.53% from the prior year.
- Non-Current Deferred Tax Liability advanced to $4.4 million in Q4 2025, from $4.3 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $10.0 million in Q4 2022 to a low of $3.7 million in Q3 2024.
- A 4-year average of $6.0 million and a median of $5.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Peak annual rise in Non-Current Deferred Tax Liability reached 16.59% in 2025, while the deepest fall reached 39.56% in 2025.
- Tracing IMTX's Non-Current Deferred Tax Liability over 4 years: stood at $10.0 million in 2022, then slipped by 19.75% to $8.0 million in 2023, then fell by 22.79% to $6.2 million in 2024, then fell by 28.55% to $4.4 million in 2025.
- Business Quant data shows IMTX's Non-Current Deferred Tax Liability at $4.4 million in Q4 2025, $4.3 million in Q3 2025, and $4.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Immatics | 1.14 Bn | 1.14 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.43 Mn |
| Dec 31, 2025 | 4.43 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Sep 30, 2025 | 4.30 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Jun 30, 2025 | 4.31 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Mar 31, 2025 | 5.06 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Dec 31, 2024 | 6.20 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Jun 30, 2024 | 7.13 Mn |
| Mar 31, 2024 | 7.23 Mn |
| Mar 31, 2024 | 7.23 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Dec 31, 2022 | 10.01 Mn |
| Dec 31, 2022 | 10.01 Mn |